Concepedia

An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients

Marieke A. Vollebergh, Esther H. Lips, Petra M. Nederlof, Lodewijk F.A. Wessels, Marjanka K. Schmidt, Erik H. van Beers, Sten Cornelissen, M. Holtkamp, Femke E. Froklage, Elisabeth G.E. de Vries,

Annals of Oncology · 2010 · 211 citations · 40 references

DOIFull text

Open access

Concepts

References

40

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from <i>BRCA</i> Mutation Carriers

Peter C.C. Fong, David S. Boss, Timothy A. Yap et al. · New England Journal of Medicine · 2009 · 3.6K citations · Full text

, , +17

Diagnosis of multiple cancer types by shrunken centroids of gene expression

Robert Tibshirani, Trevor Hastie, Balasubramanian Narasimhan et al. · Proceedings of the National Academy of Sciences · 2002 · 2.9K citations

, , +13

Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

Torsten O. Nielsen, Forrest D. Hsu, Kristin C. Jensen et al. · Clinical Cancer Research · 2004 · 2.7K citations · Full text

, , +17

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

M. William Audeh, James Carmichael, Richard T. Penson et al. · The Lancet · 2010 · 2.3K citations

, , +16

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)

Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei et al. · JNCI Journal of the National Cancer Institute · 2005 · 2.1K citations · Full text

, , +16